Tower Research Capital (TRC)’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Tower Research Capital (TRC)’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-216	Closed	-$16K	–	5677
2015 Q3	$16K	Sell	216 -298	-58%	-$22.3K	﹤0.01%	1956
2015 Q2	$39K	Buy	514 +1	+0.2%	+$54	﹤0.01%	1571
2015 Q1	$26K	Buy	+513	New	+$21.5K	﹤0.01%	2056
2014 Q4	–	Sell	-388	Closed	-$13K	–	5337
2014 Q3	$13K	Buy	+388	New	+$13.7K	﹤0.01%	2677
2014 Q1	–	Sell	-6,654	Closed	-$298K	–	5377
2013 Q4	$248K	Buy	6,654 +5,543	+499%	+$230K	0.04%	414
2013 Q3	$51K	Sell	1,111 -1,244	-53%	-$37.2K	0.01%	1906
2013 Q2	$64K	Buy	+2,355	New	+$53.9K	0.01%	774

Tower Research Capital (TRC)'s KYTH Position: Q4 2015 in Review

Tower Research Capital (TRC) sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 216 shares — an estimated $16K sold.

Tower Research Capital (TRC) first reported a position in KYTH in Q2 2013 and held it in 7 quarters. The position peaked at $248K in Q4 2013. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

Tower Research Capital (TRC) reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
Tower Research Capital (TRC) sold 216 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $16K.
Tower Research Capital (TRC) first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 7 quarters.
Tower Research Capital (TRC)'s KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $248K in Q4 2013.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.